J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

What does the bio­phar­ma in­dus­try think of Pres­i­dent Don­ald Trump’s tar­iff plans? Just ask Joaquin Du­a­to.

The John­son & John­son CEO sub­tly but as­sertive­ly crit­i­cized …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER